http://www.marketwatch.com/news/story.asp?guid=%7B20C06575-04D4-B545-71F4-CFDE0BD1906E%7D&siteid=rss&rss=1
FDA advisers vote 8-6 Friday to recommend the agency grant accelerated approval to Sarepta Therapeutics Inc.’s gene therapy for Duchenne muscular dystrophy…
: FDA advisers narrowly back accelerated approval of Sarepta gene therapy
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Germany’s Merz calls for EU budget cuts of hundreds of billions
- Persistently high inflation to nag global economy, say economists: Reuters poll
- Dollar firms to one-month high as markets mull Fed hike odds
- Why BofA says July Fed rate hike would be “unprecedented”
- Brazil’s inflation slows to 0.06% in mid-July, below forecast
- SK Hynix Perpetual Contract Drops 18% After Price Anomaly
- Ethereum (ETH) Price Holds Descending Channel Support: Key Levels to Watch
- Saylor’s $25 Million STRC Buyback Raises Eyebrows, Here’s Why
- Flare (FLR) Price Prediction 2026, 2027 – 2030: Is FLR Setting the Stage for a Long-Term Breakout?
- IMF chief visits Argentina as 2027 debt hurdle looms
More from UncategorizedMore posts in Uncategorized »
- Germany’s Merz calls for EU budget cuts of hundreds of billions
- Persistently high inflation to nag global economy, say economists: Reuters poll
- Dollar firms to one-month high as markets mull Fed hike odds
- Why BofA says July Fed rate hike would be “unprecedented”
- Brazil’s inflation slows to 0.06% in mid-July, below forecast
- SK Hynix Perpetual Contract Drops 18% After Price Anomaly
- Ethereum (ETH) Price Holds Descending Channel Support: Key Levels to Watch
- Saylor’s $25 Million STRC Buyback Raises Eyebrows, Here’s Why
- Flare (FLR) Price Prediction 2026, 2027 – 2030: Is FLR Setting the Stage for a Long-Term Breakout?
- How Public Equity Can Promote a Revived American Democracy
